LAURA BURKE: Open Payments
NPI 1245672484 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 24 payments from 11 companies in 2025. Trend: 2023 $168 · 2024 $942 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $94 |
| Calliditas Therapeutics US Inc. | 2 | $69 |
| ViiV Healthcare Company | 2 | $59 |
| Ardelyx, Inc. | 2 | $59 |
| Shionogi Inc | 2 | $57 |
| Insmed, Inc. | 3 | $56 |
| Paratek Pharmaceuticals, Inc. | 2 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $21 |
Products named: EMBLAVEO, TARPEYO, CABENUVA, IBSRELA, Fetroja, Arikayce, NUZYRA, VOWST.
Industry payments across IN — which companies pay providers there.
